Analyst Shanaka Anslem Perera remarked this was “foundational change,” as if anyone ever needed “foundational” to be a verb. Suddenly, banks became crypto-loving parents, offering new toys (structured notes, ETFs), safety nets (bureaucratic frameworks), and a stern lecture on volatility. Bitcoin, once the rogue teen, got enrolled in a Montessori school for asset managers. 🏫
I won’t sugarcoat it – Braidwell’s latest move reads like a panicked text you send in the middle of a volatile position. According to their November 14 SEC filing, they’ve shelled out for 910,476 shares of Hinge Health, amassing a $44.7 million stake. For context, that’s more liquid assets than I have at the bottom of a tequila bottle on a Tuesday. And this from a fund that apparantly forgot to mention Hinge in their last quarterly report – impressive filing discipline, lads.
The Securities and Exchange Commission, that ever-vigilant arbiter of financial propriety, disclosed in a November 14 filing that Braidwell had woven itself into the tapestry of Soleno Therapeutics (SLNO +5.73%). The fund, with the precision of a clockmaker’s hand, acquired nearly 1.3 million shares, swelling its stake to $86.7 million by the close of the third quarter. This new holding, a modest 3.5% of the fund’s reportable U.S. equity assets, betrays a peculiar faith in a company that once languished in the shadow of its own aspirations.
This legislative masterpiece does more than merely refine legal jargon; it is a grand gesture, a sweeping declaration that the digital realm shall no longer be treated as a bastard child of the law. 🌐 English law, with its penchant for categorizing the uncategorizable, now embraces emerging technologies with open arms-or so we are led to believe. Ownership rights shall be clearer, disputes shall be smoother, and institutions shall flock like pigeons to Trafalgar Square. How quaint! 🐦
It sounds about as exciting as watching paint dry, until you realize it’s like turning on a light in a room full of very confused digital squirrels. Suddenly, crypto isn’t just a weird experiment that some suits are playing with-they’re good enough to argue about in court. Fancy that! 🏛️
The air grows thin for sellers, their tokens dwindling like snowflakes in a furnace. Traders, ever the vultures, circle, sensing the tightening noose of supply. Demand, that fickle mistress, begins her dance, whispering promises of stability in SHIB’s ear. 🕊️💸
In the four-hour timeframe (because who doesn’t love a good four-hour drama?), the ETH/USD pair has formed a “higher low,” which is basically crypto’s way of saying, “I’m not dead yet!” 🦜 It’s been closing above its falling logarithmic trend and the resistance level around $3,082, which is about as exciting as watching paint dry, but with more zeros involved.
And it gets juicier! Momentum indicators are finally easing off their grumpy, bearish phase, and now traders are suddenly… wait for it… starting to think things could actually improve short-term! Who would have thought?
As the ink dried on the Q3 SEC filing, a curious spectacle unfolded. The firm, with the precision of a clockwork automaton, added 171,817 shares to its holdings, swelling the total stake to 286,368. The date, November 7, 2025, etched itself into the annals of financial history, a day when numbers danced like specters in the night.
According to the inimitable David Schamis, CEO of Hyperliquid Strategies, this union shall fling open the doors of the Hyperliquid [HYPE] chain and DEX to the public markets. 🌍💸 He declares, with a flourish of his metaphorical monocle: